Immediate Impact
1 from Science/Nature 50 standout
Citing Papers
Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer
2023 Standout
Exploiting innate immunity for cancer immunotherapy
2023 Standout
Works of Leonardo Forero being referenced
Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study
2008
A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Leonardo Forero | 62 | 44 | 39 | 6 | 109 | |
| Judith Anderton | 122 | 63 | 76 | 5 | 179 | |
| Ming-Mo Hou | 52 | 44 | 54 | 9 | 127 | |
| Dan-Arin Silasi | 79 | 44 | 21 | 7 | 183 | |
| Marni B. McClure | 38 | 64 | 27 | 7 | 112 | |
| Corwin Joy | 42 | 101 | 43 | 5 | 148 | |
| Francesca Pettinella | 75 | 28 | 19 | 8 | 120 | |
| Jennifer Dackor | 98 | 132 | 82 | 7 | 226 | |
| K. Cleary | 74 | 32 | 16 | 5 | 110 | |
| Khalid AbdulJabbar | 35 | 31 | 20 | 8 | 87 | |
| Jason Laskey | 37 | 79 | 44 | 4 | 109 |
All Works
Loading papers...